Cargando…

Deintensification of Treatment With Sulfonylurea and Insulin After Severe Hypoglycemia Among Older Adults With Diabetes

IMPORTANCE: Practice guidelines recommend deintensification of hypoglycemic agents among older adults with diabetes who are at high risk of hypoglycemia, yet real-world treatment deintensification practices are not well characterized. OBJECTIVE: To examine the incidence of sulfonylurea and insulin d...

Descripción completa

Detalles Bibliográficos
Autores principales:	Alexopoulos, Anastasia-Stefania, Kahkoska, Anna R., Pate, Virginia, Bradley, Marie C., Niznik, Joshua, Thorpe, Carolyn, Stürmer, Til, Buse, John
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Medical Association 2021
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8564578/ https://www.ncbi.nlm.nih.gov/pubmed/34726745 http://dx.doi.org/10.1001/jamanetworkopen.2021.32215

Ejemplares similares

Cardiovascular Effectiveness of Sodium‐Glucose Cotransporter 2 Inhibitors and Glucagon‐Like Peptide‐1 Receptor Agonists in Older Patients in Routine Clinical Care With or Without History of Atherosclerotic Cardiovascular Diseases or Heart Failure
por: Htoo, Phyo T., et al.
Publicado: (2022)

Factors associated with antihypertensive treatment intensification and deintensification in older outpatients
por: Aubert, Carole E., et al.
Publicado: (2021)

Primum Non Nocere: Refocusing Our Attention on Severe Hypoglycemia Prevention
por: Kahkoska, Anna R., et al.
Publicado: (2018)

Real-world evidence on sodium-glucose cotransporter-2 inhibitor use and risk of Fournier’s gangrene
por: Yang, Jeff Yufeng, et al.
Publicado: (2020)

Role of Octreotide in Sulfonylurea-Induced Hypoglycemia
por: Zafar, Sheema, et al.
Publicado: (2021)

Comparative Propensity-Weighted Mortality After Isolated Acute Traumatic Axis Fractures in Older Adults
por: Catalino, Michael P., et al.
Publicado: (2020)

Sulfonylurea-Induced Hypoglycemia in a Patient With Cirrhosis
por: Braet, Corey, et al.
Publicado: (2020)

Cardiovascular Outcomes of α-Blockers vs 5-α Reductase Inhibitors for Benign Prostatic Hyperplasia
por: Zhang, Jiandong, et al.
Publicado: (2023)

Doxorubicin Dose Deintensification in Pediatric Osteosarcoma, Is Less Better?
por: Halalsheh, Hadeel, et al.
Publicado: (2023)

Cancer Incidence Among Those Initiating Insulin Therapy With Glargine Versus Human NPH Insulin
por: Stürmer, Til, et al.
Publicado: (2013)

Gender Disparities in Surgical Treatment of Axis Fractures in Older Adults
por: Catalino, Michael P., et al.
Publicado: (2019)

The comparative risk of acute kidney injury of vancomycin relative to other common antibiotics
por: Gaggl, Martina, et al.
Publicado: (2020)

Diabetes Medication Changes in Older Adults With Type 2 Diabetes: Insights Into Physician Factors and Questions Ahead
por: Alexopoulos, Anastasia-Stefania, et al.
Publicado: (2023)

SAT-LB110 Sulfonylurea-Induced Hypoglycemia: To Use Octreotide or Not
por: Romeu, Jose, et al.
Publicado: (2020)

Pharmacogenetics of Hypoglycemia Associated with Sulfonylurea Therapy in Usual Clinical Care
por: Mitchell, Sabrina L, et al.
Publicado: (2020)

A Case of Hypoglycemia With Concomitant Use of a Sulfonylurea and Clopidogrel
por: Ruiz, Brent, et al.
Publicado: (2022)

The effectiveness of octreotide at different doses for sulfonylurea-induced hypoglycemia following overdose
por: Gul, M, et al.
Publicado: (2007)

Stress Cardiomyopathy Induced by Refractory Hypoglycemia Due to Acute Sulfonylurea Intoxication
por: Shah, Binoy K, et al.
Publicado: (2023)

Deintensification Strategies Using Proton Beam Therapy for HPV-Related Oropharyngeal Cancer
por: Gamez, Mauricio E., et al.
Publicado: (2021)

Current Evidence of a Deintensification Strategy for Patients with HPV-Related Oropharyngeal Cancer
por: Sung, Soo-Yoon, et al.
Publicado: (2022)

Glycemic treatment deintensification practices in nursing home residents with type 2 diabetes
por: Lederle, Lauren I., et al.
Publicado: (2022)

Treatment outcomes and radiotherapy deintensification strategies in human papillomavirus-associated tonsil cancer
por: Lee, Joongyo, et al.
Publicado: (2022)

A real world comparison of sulfonylurea and insulin vs. incretin-based treatments in patients not controlled on prior metformin monotherapy
por: Gitt, Anselm K, et al.
Publicado: (2015)

Deprescribing research in nursing home residents using routinely collected healthcare data: a conceptual framework
por: Thorpe, Carolyn, et al.
Publicado: (2023)

Discordant Timing of Hypoglycemic Agent Screening Causing Delayed Diagnosis of Sulfonylurea-Induced Hypoglycemia
por: Folick, Andrew, et al.
Publicado: (2022)

SAT156 Two Cases Of Hypoglycemia From Inhalation Of Heroin Adulterated With A Sulfonylurea
por: Kim, Keun Young, et al.
Publicado: (2023)

Effect of the addition of rosiglitazone to metformin or sulfonylureas versus metformin/sulfonylurea combination therapy on ambulatory blood pressure in people with type 2 diabetes: A randomized controlled trial (the RECORD study)
por: Komajda, Michel, et al.
Publicado: (2008)

Effect of beta blocker use and type on hypoglycemia risk among hospitalized insulin requiring patients
por: Dungan, Kathleen, et al.
Publicado: (2019)

Duration of type 2 diabetes does not appear to moderate hypoglycaemia rate with insulin degludec versus insulin glargine U100
por: Alexopoulos, Anastasia‐Stefania, et al.
Publicado: (2021)

Development of Osteoarthritis in Adults With Type 2 Diabetes Treated With Metformin vs a Sulfonylurea
por: Baker, Matthew C., et al.
Publicado: (2023)

Initial Sulfonylurea Use and Subsequent Insulin Therapy in Older Subjects with Type 2 Diabetes Mellitus
por: Fu, Alex Z., et al.
Publicado: (2012)

Neuroendocrine and sympathetic responses to an orexin receptor antagonist, SB-649868, and Alprazolam following insulin-induced hypoglycemia in humans
por: Patel, Ameera X., et al.
Publicado: (2014)

A Cross-Sectional Study of Overtreatment and Deintensification of Antidiabetic and Antihypertensive Medications in Diabetes Mellitus: The TEMD Overtreatment Study
por: Sonmez, Alper, et al.
Publicado: (2020)

Metformin, Sulfonylureas, or Other Antidiabetes Drugs and the Risk of Lactic Acidosis or Hypoglycemia: A nested case-control analysis
por: Bodmer, Michael, et al.
Publicado: (2008)

Comparative Effectiveness of Sodium-Glucose Cotransporter 2 Inhibitors vs Sulfonylureas in Patients With Type 2 Diabetes
por: Xie, Yan, et al.
Publicado: (2021)

Optical control of insulin release using a photoswitchable sulfonylurea
por: Broichhagen, Johannes, et al.
Publicado: (2014)

Deprescribing in Older Adults: Is Evidence for Continued Medication Use Generalizable Beyond Age 75?
por: Niznik, Joshua
Publicado: (2020)

Electronic Medical Record Cancer Incidence over Six Years Comparing New Users of Glargine with New Users of NPH Insulin
por: Lim, Soo, et al.
Publicado: (2014)

Association Between Glucagon-Like Peptide 1 Receptor Agonist and Sodium–Glucose Cotransporter 2 Inhibitor Use and COVID-19 Outcomes
por: Kahkoska, Anna R., et al.
Publicado: (2021)

Associations of hypoglycemia, glycemic variability and risk of cardiac arrhythmias in insulin-treated patients with type 2 diabetes: a prospective, observational study
por: Andersen, Andreas, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ll0uc04un3mfknol1s3qclq85m